Integrated BioPharma Statistics
Total Valuation
INBP has a market cap or net worth of 9.03 million. The enterprise value is 7.20 million.
| Market Cap | 9.03M |
| Enterprise Value | 7.20M |
Important Dates
The last earnings date was Monday, May 12, 2025.
| Earnings Date | May 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
INBP has 30.92 million shares outstanding. The number of shares has increased by 5.08% in one year.
| Current Share Class | 30.92M |
| Shares Outstanding | 30.92M |
| Shares Change (YoY) | +5.08% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 17.15% |
| Owned by Institutions (%) | 0.06% |
| Float | 9.41M |
Valuation Ratios
The trailing PE ratio is 7.02.
| PE Ratio | 7.02 |
| Forward PE | n/a |
| PS Ratio | 0.17 |
| PB Ratio | 0.44 |
| P/TBV Ratio | 0.44 |
| P/FCF Ratio | 9.60 |
| P/OCF Ratio | 7.01 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.27, with an EV/FCF ratio of 7.66.
| EV / Earnings | 5.75 |
| EV / Sales | 0.14 |
| EV / EBITDA | 2.27 |
| EV / EBIT | 3.93 |
| EV / FCF | 7.66 |
Financial Position
The company has a current ratio of 3.72, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.72 |
| Quick Ratio | 1.61 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 1.21 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 6.38% and return on invested capital (ROIC) is 5.40%.
| Return on Equity (ROE) | 6.38% |
| Return on Assets (ROA) | 4.36% |
| Return on Invested Capital (ROIC) | 5.40% |
| Return on Capital Employed (ROCE) | 8.87% |
| Revenue Per Employee | 360,027 |
| Profits Per Employee | 8,531 |
| Employee Count | 147 |
| Asset Turnover | 2.01 |
| Inventory Turnover | 4.48 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.00% in the last 52 weeks. The beta is 0.80, so INBP's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | +16.00% |
| 50-Day Moving Average | 0.31 |
| 200-Day Moving Average | 0.30 |
| Relative Strength Index (RSI) | 43.60 |
| Average Volume (20 Days) | 23,219 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.32 |
Income Statement
In the last 12 months, INBP had revenue of 52.92 million and earned 1.25 million in profits. Earnings per share was 0.04.
| Revenue | 52.92M |
| Gross Profit | 5.38M |
| Operating Income | 1.83M |
| Pretax Income | 1.88M |
| Net Income | 1.25M |
| EBITDA | 2.17M |
| EBIT | 1.83M |
| Earnings Per Share (EPS) | 0.04 |
Balance Sheet
The company has 2.96 million in cash and 1.14 million in debt, giving a net cash position of 1.83 million or 0.06 per share.
| Cash & Cash Equivalents | 2.96M |
| Total Debt | 1.14M |
| Net Cash | 1.83M |
| Net Cash Per Share | 0.06 |
| Equity (Book Value) | 20.38M |
| Book Value Per Share | 0.67 |
| Working Capital | 13.57M |
Cash Flow
In the last 12 months, operating cash flow was 1.29 million and capital expenditures -347,000, giving a free cash flow of 941,000.
| Operating Cash Flow | 1.29M |
| Capital Expenditures | -347,000 |
| Free Cash Flow | 941,000 |
| FCF Per Share | 0.03 |
Margins
Gross margin is 10.16%, with operating and profit margins of 3.46% and 2.37%.
| Gross Margin | 10.16% |
| Operating Margin | 3.46% |
| Pretax Margin | 3.55% |
| Profit Margin | 2.37% |
| EBITDA Margin | 4.09% |
| EBIT Margin | 3.46% |
| FCF Margin | 1.78% |
Dividends & Yields
INBP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.08% |
| Shareholder Yield | n/a |
| Earnings Yield | 13.89% |
| FCF Yield | 10.42% |
Stock Splits
The last stock split was on July 2, 1996. It was a reverse split with a ratio of 0.25.
| Last Split Date | Jul 2, 1996 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
INBP has an Altman Z-Score of 2.21. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.21 |
| Piotroski F-Score | n/a |